Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02859857
Title Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bexion Pharmaceuticals, LLC.
Indications

high grade glioma

Advanced Solid Tumor

Therapies

BXQ-350

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.